Myocardial infarct: No one size fits all

Circulation

Volumn 105, Issue 22, 2002, Pages 2577-2579

  Pfeffer, Marc A ^a   McMurray, John J V ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Coronary disease; Editorials; Heart failure; Myocardial infarction; Trials

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOLYTIC AGENT;

CLINICAL FEATURE; DEFIBRILLATION; DISEASE MARKER; EDITORIAL; FIBRINOLYTIC THERAPY; HEALTH CARE DELIVERY; HEART INFARCTION; HUMAN; MORBIDITY; MORTALITY; OUTCOMES RESEARCH; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SURVIVAL RATE;

ADRENERGIC BETA-ANTAGONISTS; ALDOSTERONE ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CALCIUM CHANNEL BLOCKERS; CLINICAL TRIALS; CORONARY CARE UNITS; DIFFUSION OF INNOVATION; DISEASE MANAGEMENT; DRUG THERAPY, COMBINATION; FIBRINOLYTIC AGENTS; HEART; HUMANS; MYOCARDIAL INFARCTION; RECEPTORS, ALDOSTERONE; RISK ASSESSMENT; TIME FACTORS; TREATMENT OUTCOME;

EID: 0037024234     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000020729.75885.39     Document Type: Editorial

References (22)

1. Thirteenth Bowditch Lecture. The determinants of myocardial oxygen consumption
2. Factors influencing infarct size following experimental coronary artery occlusion
3. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17 187 cases of suspected acute myocardial infarction
4. Indications for ACE inhibitors in the early treatment of acute myocardial infarction: Systematic overview of individual data from 100 000 patients in randomized trials
5. Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: A systematic overview of data from individual patients
6. 1999 Update: ACC/AHA guidelines for the management of patients with Acute Myocardial Infarction: Executive Summary and Recommendations: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction)
7. A coronary prognostic index for grading the severity of infarction
8. Coronary prognostic index for predicting survival after recovery from acute myocardial infarction
9. Treatment of myocardial infarction in a coronary care unit: A two-year experience with 250 patients
10. Early revascularization in acute myocardial infarction complicated by cardiogenic shock
11. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction: Results from an international trial of 41 021 patients
12. Risk stratification after myocardial infarction
13. Preservation of global and regional left ventricular function after early thrombolysis in acute myocardial infarction
14. Right ventricular dysfunction and risk of heart failure and mortality following myocardial infarction
15. Heterogeneity in the management and outcomes of patients with acute myocardial infarction complicated by heart failure: The National Registry of Myocardial Infarction
16. Determinants and outcomes of congestive heart failure complicating acute coronary syndromes: Observations from the Global Registry of Acute Coronary Events
17. The effect of diltiazem on mortality and reinfarction after myocardial infarction
18. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: The CAPRICORN randomized trial
19. Comparison of the effects of losartan and captopril on mortality in patients after acute myocardial infarction: The OPTIMAAL Trial Design
20. Valsartan in Acute Myocardial Infarction Trial (VALIANT): Rationale and design
21. The EPHESUS trial: Eplerenone in patients with heart failure due to systolic dysfunction complicating acute myocardial infarction. Eplerenone Post-AMI Heart Failure Efficacy and Survival Study